Results 111 to 120 of about 766 (168)

Anticipating and overcoming resistance in blastic plasmacytoid dendritic cell neoplasm: new insights from pivekimab sunirine. [PDF]

Haematologica
Sapienza MR.
europepmc   +1 more source

Diagnosis and Management of Blastic Plasmacytoid Dendritic Cell Neoplasm. [PDF]

Int J Dermatol
Gandarillas S, Mehregan D, Wolfe S, Dasgeb B.   +3 more
europepmc   +1 more source

Shared Care Offers an Effective Framework for Managing Tagraxofusp Treatment in Blastic Plasmacytoid Dendritic Cell Neoplasm.

Acta Haematol
Ambinder A, LeBlanc TW, Levy MY, Patel AB, McCloskey J, Duffield E, Katsetos J, Mannis G.   +7 more
europepmc   +1 more source

Final safety and efficacy results from a phase 1/2 study of tagraxofusp, a CD123-targeted therapy, for myelofibrosis. [PDF]

Blood Neoplasia
Yacoub A, Ali H, Gupta V, Wang ES, Patnaik MM, Schiller GJ, Taparia M, Mughal TI, Lindsay R, Galleu A, Gupta I, Pemmaraju N.   +11 more
europepmc   +1 more source

Correction to "Hematopoietic effects of tagraxofusp in treatment-naive patients with blastic plasmacytoid dendritic cell neoplasm". [PDF]

Cancer
europepmc   +1 more source

Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Series and Review of Literature. [PDF]

Cureus
Staessens S, De Beule N, Trullemans F, De Becker A.   +3 more
europepmc   +1 more source

Relapsing Blastic Plasmacytoid Dendritic Cell Neoplasm With Neurologic Involvement. [PDF]

Cureus
Rahman Z, Haley A, Gandhi S, Mohamed A, Parza K, Quan JR.   +5 more
europepmc   +1 more source

A phase I/II study of tagraxofusp in Japanese patients with blastic plasmacytoid dendritic cell neoplasm. [PDF]

Int J Hematol
Yokota A, Munakata W, Kiguchi T, Ogawa Y, Hino M, Kato K, Chiba M, Kawasaki D, Wasa K, Mikasa T, Takeuchi K, Izutsu K, Suzuki R, Study Group.   +13 more
europepmc   +1 more source

Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell Neoplasm. [PDF]

J Clin Oncol
Pemmaraju N, Marconi G, Montesinos P, Lane AA, Mazzarella L, Sallman DA, Ulrickson ML, Schiller GJ, Erba HP, Wang ES, Walter RB, Deconinck E, Aribi A, Legrand O, Lebon D, Maisano V, Martinelli G, DeAngelo DJ, Derenzini E, Du Y, Lakshmikanthan S, Potluri J, Kantarjian HM, Daver NG.   +23 more
europepmc   +1 more source

Venetoclax and hypomethylating agents versus tagraxofusp in older patients with blastic plasmacytoid dendritic cell neoplasm. [PDF]

Ann Hematol
Lee BJ.
europepmc   +1 more source